EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 226 filers reported holding EDITAS MEDICINE INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $224,750 | -18.3% | 31,000 | 0.0% | 0.04% | -22.2% |
| Q4 2022 | $274,970 | +116.5% | 31,000 | +198.1% | 0.04% | +104.5% |
| Q3 2022 | $127,000 | +3.3% | 10,400 | 0.0% | 0.02% | +4.8% |
| Q2 2022 | $123,000 | -37.9% | 10,400 | 0.0% | 0.02% | -44.7% |
| Q1 2022 | $198,000 | -28.3% | 10,400 | 0.0% | 0.04% | -37.7% |
| Q4 2021 | $276,000 | -63.9% | 10,400 | -44.1% | 0.06% | -63.7% |
| Q3 2021 | $764,000 | -56.5% | 18,600 | -40.0% | 0.17% | -53.8% |
| Q2 2021 | $1,756,000 | +190.2% | 31,000 | +115.3% | 0.36% | +191.2% |
| Q1 2021 | $605,000 | -71.9% | 14,400 | -53.2% | 0.12% | -77.9% |
| Q4 2020 | $2,156,000 | +0.4% | 30,750 | -59.8% | 0.56% | -0.5% |
| Q3 2020 | $2,147,000 | -28.8% | 76,500 | -25.0% | 0.57% | -26.1% |
| Q2 2020 | $3,017,000 | +48.4% | 102,000 | -0.5% | 0.77% | +40.3% |
| Q1 2020 | $2,033,000 | +3.3% | 102,500 | +54.1% | 0.55% | -12.6% |
| Q4 2019 | $1,969,000 | – | 66,500 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |